https://ascopost.com/news/november-2025/fda-approves-durvalumab-with-flot-for-resectable-gastric-gej-adenocarcinoma/
On November 25, 2025, the U.S. Food and Drug Administration (FDA) approved durvalumab (Imfinzi) in combination with fluorouracil, leucovorin, oxaliplatin, and...
fdadurvalumabflotresectablegastric
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.753797/full
Objective: To investigate relationship of tumor stage-based gross tumor volume (GTV) of esophageal squamous cell carcinoma (ESCC) measured on computed tomogr...
tumor stagefrontiersbasedgrossvolume